Anders Fugelli
Vorstandsvorsitzender bei Pharmasum Therapeutics AS
Profil
Anders Fugelli is the founder of Pharmasum Therapeutics AS.
Prior to founding Pharmasum Therapeutics AS, he worked as the Head of Business Development & Commercialization at Lytix Biopharma AS from 2004 to 2014.
Before that, he worked as an Assistant Director at GlaxoSmithKline, Inc. Dr. Fugelli received his undergraduate degree from Imperial College London and his doctorate from the University of London.
Aktive Positionen von Anders Fugelli
| Unternehmen | Position | Beginn |
|---|---|---|
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Anders Fugelli
| Unternehmen | Position | Ende |
|---|---|---|
| LYTIX BIOPHARMA | Direktor/Vorstandsmitglied | 29.07.2009 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Ausbildung von Anders Fugelli
| Imperial College London | Undergraduate Degree |
| University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
